EUVIMEDEUVIMED entdecken
Open Access

Do Breast Cancer Patients With Chemotherapy-induced Peripheral Neuropathy Have an Increased Risk of Radiation Dermatitis?

Dirk Rades, Martin Ballegaard

In Vivo · 2025

DOI: 10.21873/invivo.14019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Dirk Rades und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de. Hauptthemen laut MEDLINE: Breast Neoplasms, Peripheral Nervous System Diseases, Radiodermatitis, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Patients with breast cancer scheduled for irradiation may present with peripheral neuropathy (PNP) caused by preceding taxane-based chemotherapy. Chemotherapy-related toxicity was suggested to be associated with a lower individual DNA repair capacity. A similar association was described for radiation-related toxicity. We investigated whether patients with taxane-induced PNP have an increased risk of radiation dermatitis. PATIENTS AND METHODS: In a retrospective cohort of 129 patients irradiated for breast cancer following taxane-based chemotherapy, PNP plus 14 characteristics were evaluated for associations with grade ≥2 radiation dermatitis. RESULTS: No, mild, and moderate to severe PNP were associated with grade ≥2 dermatitis rates of 22.2%, 27.7%, and 37.8% (p=0.123). On multivariate analysis, grade ≥2 dermatitis was significantly associated with normo-fractionated radiotherapy (p=0.032) and a body mass index ≥30 kg/m2 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPeripheral Nervous System DiseasesRadiodermatitisAntineoplastic AgentsHumansFemaleMiddle AgedAgedRetrospective StudiesAdultRisk FactorsTaxoidsAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Breast cancerirradiationperipheral neuropathyradiation dermatitistaxane-based chemotherapy

Substanzen

TaxoidsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
  • Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Zitieren

APA

Rades, D., & Ballegaard, M. (2025). Do Breast Cancer Patients With Chemotherapy-induced Peripheral Neuropathy Have an Increased Risk of Radiation Dermatitis?. In Vivo. https://doi.org/10.21873/invivo.14019

Vancouver

Rades D, Ballegaard M. Do Breast Cancer Patients With Chemotherapy-induced Peripheral Neuropathy Have an Increased Risk of Radiation Dermatitis?. In Vivo. 2025. doi:10.21873/invivo.14019

BibTeX
@article{Rades2025,
  author = {Rades, Dirk and Ballegaard, Martin},
  title = {Do Breast Cancer Patients With Chemotherapy-induced Peripheral Neuropathy Have an Increased Risk of Radiation Dermatitis?},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14019}
}
Kostenlos starten →